Showing results (11-20 of 162) with videos related to

Sort By:
Pageof 17
Blood Cells, Molecules & Diseases|August 19, 2004
Myeloma cells (5TMM) and their interactions with the marrow microenvironmentEline Menu, Kewal Asosingh, Ivan Van Riet, et al.
Clinical & Translational Immunology|May 2, 2020
Identification of the immune checkpoint signature of multiple myeloma using mass cytometry-based single-cell analysisJinheng Wang, Yongjiang Zheng, Chenggong Tu, et al.
Stem Cells (Dayton, Ohio)|November 22, 2011
Bone marrow-derived mesenchymal stromal cells are attracted by multiple myeloma cell-produced chemokine CCL25 and favor myeloma cell growth in vitro and in vivoSong Xu, Eline Menu, Ann De Becker, et al.
Cancers|November 13, 2013
Epigenetic modulating agents as a new therapeutic approach in multiple myelomaKen Maes, Eline Menu, Els Van Valckenborgh, et al.
Advances in Hematology|October 29, 2010
The effects of forodesine in murine and human multiple myeloma cellsLiesbeth Bieghs, Jo Caers, Elke De Bruyne, et al.
Experimental Hematology & Oncology|July 10, 2024
Fueling CARs: metabolic strategies to enhance CAR T-cell therapyArne Van der Vreken, Karin Vanderkerken, Elke De Bruyne, et al.
Frontiers in Genetics|September 3, 2019
The Use of Murine Models for Studying Mechanistic Insights of Genomic Instability in Multiple MyelomaPhilip Vlummens, Kim De Veirman, Eline Menu, et al.
Biochemical and Biophysical Research Communications|November 1, 2012
Dll1/Notch activation contributes to bortezomib resistance by upregulating CYP1A1 in multiple myelomaDehui Xu, Jinsong Hu, Elke De Bruyne, et al.
Brain, Behavior, and Immunity|December 24, 2025
Neural control of Immunotherapy: how Tumor-innervation shapes Anti-Tumor immune responsesHatice Satilmis, Adrien Denis, Karin Vanderkerken, et al.
Frontiers in Oncology|January 9, 2019
The Epigenome in Multiple Myeloma: Impact on Tumor Cell Plasticity and Drug ResponseEva De Smedt, Hui Lui, Ken Maes, et al.
Pageof 17